EUVIMEDEUVIMED entdecken
Crossref

Investigating the Antifibrotic Action of Foeniculum vulgare Root Bark Volatile Oil Through the HK2/PKM2/LDHA Pathway

Kehong Ming iD, Lieyang Peng, Yijing Pan, Meiliang Zhu, Yi Xiao, Siyi Ye, Kang Xu iD, Xianqiong Liu

Phytotherapy Research · 2025

DOI: 10.1002/ptr.70050 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytotherapy Research, 2025. Verfasst von Kehong Ming und 7 weiteren Autor:innen. Beteiligte Einrichtung: Hubei Provincial Engineering Technology Research Center for Chinese Medicine Processing, School of Pharmacy, Hubei University of Chinese Medicine, Wu…. Hauptthemen laut MEDLINE: Oils, Volatile, Foeniculum, Liver Cirrhosis, Antifibrotic Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Department of Science and Technology of Xinjiang Uygur Autonomous Region, Natural Science Foundation of Hubei Province, China, Natural Science Foundation of Hubei Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Foeniculum vulgare root bark (FVRB), a traditional ethnomedicine, demonstrates hepatoprotective properties and has been clinically employed in managing liver fibrosis. As volatile oils represent principal bioactive constituents of FVRB, the therapeutic potential of F. vulgare root bark volatile oil (FVRBO) against liver fibrosis remains unelucidated. This study investigates the antifibrotic mechanisms of FVRBO through integrated in vitro and in vivo approaches. The FVRBO was extracted using the steam distillation method, and the content of its main components was determined by gas chromatography. Liver fibrosis models were established using CCl 4 ‐induced mice and TGF‐β1‐induced JS‐1 cells. Antifibrotic efficacy was validated through significant downregulation of fibrotic markers and inflammatory cytokines. Integrated transcriptomic and metabolomic analyses revealed FVRBO's mechanism. The principal constituents of FVRBO were quantified as dillapiole, apiole, and myristicin, with the extraction method demonstrating consistent stability. In vivo, FVRBO significantly attenuated CCl 4 ‐induced liver injury in mice, as evidenced by decreased liver and spleen indices, reduced serum ALT and AST levels, attenuated inflammatory infiltration, and suppressed collagen deposition in hepatic tissue. In vitro, FVRBO effectively inhibited TGF‐β‐induced JS‐1 cell activation and downregulated fibrotic markers at mRNA and protein levels. Integrated transcriptomic‐metabolomic analysis revealed FVRBO exerts antifibrotic efficacy by regulating the glycolysis pathway and suppressing the expression of HK2, PKM2, and LDHA. FVRBO exerts antifibrotic effects by modulating the glycolytic pathway and its associated gene expression. This study provides mechanistic evidence for FVRBO as a phytopharmaceutical candidate and establishes a foundation for developing natural‐product‐based anti‐fibrotic therapeutics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Oils, VolatileFoeniculumLiver CirrhosisAntifibrotic AgentsAnimalsMicePlant BarkPlant RootsMaleCell LineLiverMice, Inbred C57BLMembrane Proteins

Stichwörter der Autor:innen

Foeniculum vulgare root barkglycolysisliver fibrosismetabolomicstranscriptomicsvolatile oil

Substanzen

Oils, VolatileAntifibrotic AgentsMembrane Proteins

Autor:innen und Institutionen

  • Hubei Provincial Engineering Technology Research Center for Chinese Medicine Processing, School of Pharmacy, Hubei University of Chinese Medicine, Wuhan, China.
  • Hubei Shizhen Laboratory, Wuhan, China.
  • Center of Traditional Chinese Medicine Modernization for Liver Diseases, Hubei University of Chinese Medicine, Wuhan, China.

ORCID-Profile: Kehong Ming, Kang Xu

Förderung

  • Department of Science and Technology of Xinjiang Uygur Autonomous Region
  • Natural Science Foundation of Hubei Province, China
  • Natural Science Foundation of Hubei Province

Zitieren

APA

Ming, K., Peng, L., Pan, Y., Zhu, M., Xiao, Y., Ye, S., Xu, K., & Liu, X. (2025). Investigating the Antifibrotic Action of Foeniculum vulgare Root Bark Volatile Oil Through the HK2/PKM2/LDHA Pathway. Phytotherapy Research. https://doi.org/10.1002/ptr.70050

Vancouver

Ming K, Peng L, Pan Y, Zhu M, Xiao Y, Ye S, et al. Investigating the Antifibrotic Action of Foeniculum vulgare Root Bark Volatile Oil Through the HK2/PKM2/LDHA Pathway. Phytotherapy Research. 2025. doi:10.1002/ptr.70050

BibTeX
@article{Ming2025,
  author = {Ming, Kehong and Peng, Lieyang and Pan, Yijing and Zhu, Meiliang and Xiao, Yi and Ye, Siyi and Xu, Kang and Liu, Xianqiong},
  title = {Investigating the Antifibrotic Action of Foeniculum vulgare Root Bark Volatile Oil Through the HK2/PKM2/LDHA Pathway},
  journal = {Phytotherapy Research},
  year = {2025},
  doi = {10.1002/ptr.70050}
}
Kostenlos starten →